v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 15,874 $ 15,413
Account receivable, net 949,034
Deposits, prepayments and other receivables 4,825 8,963
Total Current Assets 969,733 24,376
NON-CURRENT ASSETS    
Deferred tax assets, net 13,355
Total Non Current Assets 13,355
TOTAL ASSETS 969,733 37,731
CURRENT LIABILITIES    
Accounts payable 820,350
Other payables 34,071 80,517
Tax payable 23,530
Total current liabilities 1,287,621 400,013
TOTAL LIABILITIES 1,287,621 400,013
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ DEFICIT    
Common stock - 600,000,000 shares authorized, par value $0.001, 74,228,185 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 74,228 74,228
Additional paid-in capital 70,736,456 70,736,456
Accumulated deficit (71,130,231) (71,175,182)
Accumulated other comprehensive income (425) 132
Total shareholders’ deficit (317,888) (362,282)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 969,733 37,731
Related Party    
CURRENT LIABILITIES    
Due to related parties 409,670 319,496
Series A Convertible Preferred Stock    
SHAREHOLDERS’ DEFICIT    
Preferred Stock 2,083 2,083
Series L Preferred stock    
SHAREHOLDERS’ DEFICIT    
Preferred Stock $ 1 $ 1